Genocea Biosciences Inc ROCE
Cos'è ROCE di Genocea Biosciences Inc?
ROCE di Genocea Biosciences Inc è -175.11%
Qual è la definizione di ROCE?
Il ritorno sul capitale investito (ROCE) è un rapporto finanziario che misura la redditività di un'azienda e l'efficienza con cui viene utilizzato il suo capitale.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE di aziende nel Health Care settore su NASDAQ rispetto a Genocea Biosciences Inc
Cosa fa Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Aziende con roce simili a Genocea Biosciences Inc
- UrbanGold Minerals ha ROCE di -176.34%
- Elys Game Technology ha ROCE di -176.22%
- Biohaven Ltd ha ROCE di -175.96%
- Asiamet Resources ha ROCE di -175.74%
- Elsight ha ROCE di -175.70%
- Capricor Therapeutics Inc ha ROCE di -175.51%
- Genocea Biosciences Inc ha ROCE di -175.11%
- Sanibel Ventures ha ROCE di -175.10%
- Workhorse Inc ha ROCE di -174.48%
- Greenwich LifeSciences ha ROCE di -173.92%
- Lordstown Motors ha ROCE di -173.29%
- Satsuma Pharmaceuticals ha ROCE di -172.20%
- Oncopeptides AB (publ) ha ROCE di -172.14%